Alibaba Health Information Technology Ltd
HKEX:241
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alibaba Health Information Technology Ltd
HKEX:241
|
HK |
|
Spectur Ltd
ASX:SP3
|
AU |
|
T
|
Tripar Multivision Plus Tbk PT
IDX:RAAM
|
ID |
Wall Street
Price Targets
Price Targets Summary
Alibaba Health Information Technology Ltd
According to Wall Street analysts, the average 1-year price target for Alibaba Health Information Technology Ltd is 6.12 HKD with a low forecast of 4.14 HKD and a high forecast of 11.34 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Alibaba Health Information Technology Ltd's stock price target?
Price Target
6.12
HKD
According to Wall Street analysts, the average 1-year price target for Alibaba Health Information Technology Ltd is 6.12 HKD with a low forecast of 4.14 HKD and a high forecast of 11.34 HKD.
What is Alibaba Health Information Technology Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the compound annual growth rate for Alibaba Health Information Technology Ltd's revenue is 40%. The projected CAGR for the next 8 years is 12%.
What is Alibaba Health Information Technology Ltd's Operating Income forecast?
Projected CAGR
18%
The compound annual growth rate of Alibaba Health Information Technology Ltd's operating income for the next 8 years is 18%.
What is Alibaba Health Information Technology Ltd's Net Income forecast?
Projected CAGR
24%
The compound annual growth rate of Alibaba Health Information Technology Ltd's net income for the next 8 years is 24%.
